STOCK TITAN

Precision Peptide Company (PNGAF) Stock Price, News & Analysis

PNGAF OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
84 205 sessions, November 13, 2025 to November 16, 2026
Largest daily move
+31.2% close of December 22, 2025
1-year change
-31.4% closing prices, November 13, 2025 to November 16, 2026
1-month change
-23.5% closing prices, October 16, 2026 to November 16, 2026

Company Description

Pangea Natural Foods Inc. (OTC: PNGAF, CSE: PNGA) is a natural foods and wellness company that focuses on manufacturing, co-packing, and distributing health-oriented consumer products across North America. The company positions itself as a producer of high-quality foods that are nutritious and free of GMO ingredients, fillers, antibiotics, hormones, and bioengineered ingredients. Pangea operates in the packaged foods industry within the consumer defensive sector.

Core Business and Product Portfolio

Pangea Natural Foods describes itself as a food manufacturing company focused on producing and distributing natural and plant-based products. The company highlights that its offerings are sustainably sourced and marketed under the theme "Powered by the Earth." Its stated goal is to provide products that taste good while aligning with health and wellness priorities.

The company has developed a portfolio of branded products that it refers to as its signature items. These include Pangea Plant-Based Patties, Pangea Old Fashioned Ghee, Pangea Munchie Mix, and Pangea Energy Gel. Pangea has also announced additional products such as Pangea Chikken Nuggets, a vegan meat alternative made with three types of pea protein, and a vegan single-serving pre-workout supplement formulated with vegan honey. In addition, the company has launched 100% locally sourced cold-pressed blueberry juice with an extended shelf life, and it has described work on other functional and wellness-focused products.

Manufacturing, Quality, and Distribution

Pangea states that all of its products are manufactured in-house at a facility in the Vancouver lower mainland. According to the company, this facility has been approved by both the Canadian Food Inspection Agency and the U.S. Food and Drug Administration. Pangea emphasizes adherence to strict industry regulations and quality control processes, particularly in the context of its co-packing services.

The company notes that its products are distributed through a combination of retail and wholesale channels as well as e-commerce. Pangea reports that its branded products are available on its own online platforms and in hundreds of national retail food stores across Canada and the United States. Retail partners mentioned in company communications include chains such as Loblaws, Save-On-Foods, Sobeys, IGA Marketplace, Fresh Street Market, Choices Markets, and Whole Foods. Pangea has also disclosed that certain products, such as its Munchie Mix, are offered on select flights operated by airlines including Air Canada, WestJet, and British Airways.

Co-Packing and Third-Party Services

Beyond its own brands, Pangea has expanded into co-packing services for third-party food and beverage companies in Canada and the United States. The company describes this as a new line of business that leverages its facility and production capabilities to support other brands. Pangea states that it can tailor production lines to specific product requirements, assist partners with regulatory compliance, and provide potential cost savings on packaging, equipment, labor, and logistics. The company also highlights scalability as a feature of its operations, indicating that it can adjust production capacity to meet changing demand.

Acquisitions and Subsidiaries

Pangea Natural Foods has pursued growth through acquisitions and subsidiary development. The company entered into a share exchange agreement to acquire Glory Organic Juice Company Inc. and Glory Juice Co. Vancouver Ltd. Upon completion of this acquisition, Glory Juice entities became wholly owned subsidiaries of Pangea. Glory Juice focuses on organic health food products, including cold-pressed juices, nut and seed mylks, ready-to-blend smoothies, wellness shots, and related items. The brand emphasizes using organic ingredients sourced from local farms and incorporates practices such as upcycling seed pulp and fruit peels.

Following the acquisition, Pangea has discussed the opening of multiple Glory Juice Co. locations and the introduction of Glory Market, a concept intended to broaden the product range beyond exclusively vegan offerings to include items for carnivorous, pescatarian, vegetarian, and vegan dietary preferences. Glory Juice has also been described as offering franchising, business-to-business partnerships, co-branding, and white-label capabilities.

Wellness and Peptide Patch Platform

Pangea has also expanded into wellness technologies through its wholly owned subsidiary Amino Innovations Inc. According to company announcements, Amino Innovations has developed a peptide patch platform designed for needle-free delivery of peptides. The Amino Innovations Patch uses a bio-dissolving lattice that delivers peptides through the skin’s surface layers. The company states that this design is intended to provide equivalence to traditional injectable dosing while eliminating the need for mixing, needles, or sterile handling.

The patches are described as compact, travel-friendly, shelf-stable for several months, and designed for consistent peptide delivery. Pangea reports that the patches are developed in the United States and manufactured in a cGMP-certified facility, with each patch undergoing third-party testing for pharmaceutical-grade purity, stability, and consistency. Initial formulations referenced by the company include the "Wolverine Stack Patch," which combines BPC-157 and Thymosin Beta 4 (TB4), and a TA-1 patch aimed at immune support. Through Amino Innovations, Pangea positions itself as offering advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.

Brand Positioning and Partnerships

Pangea emphasizes branding around health, wellness, and sustainability. The company states that its products are free from GMO ingredients, fillers, antibiotics, hormones, and bioengineered ingredients, and that it partners with food scientists to formulate its product lines. It has also highlighted marketing and brand-building efforts, including a brand ambassador agreement with a professional hockey player and the engagement of executives and consultants with backgrounds in marketing, franchising, and food manufacturing.

The company has pointed to airline partnerships as an example of its distribution reach. Pangea’s Munchie Mix has been featured on flights operated by airlines such as Air Canada, WestJet, and British Airways. Pangea has characterized these relationships as part of its effort to make its products available to travelers and to participate in the airline catering market.

Market Focus and Sector Context

Within the consumer defensive sector, Pangea operates in the packaged foods and health products space, with a focus on plant-based foods, organic juices, functional snacks, and wellness-oriented items. Company communications reference broader market interest in vegan foods, pre-workout supplements, and ghee, but Pangea’s own positioning centers on natural ingredients, sustainability themes, and product innovation.

Pangea has also described its mission in terms of making health and wellness accessible, both through its own branded products and through subsidiaries such as Glory Juice and Amino Innovations. The company’s activities span packaged foods, beverages, functional nutrition, and wellness technologies, all framed within a natural and clean-label approach.

Stock and Trading Information

Pangea Natural Foods Inc. trades on the Canadian Securities Exchange under the symbol PNGA and on the U.S. over-the-counter market under the symbol PNGAF. The company’s communications describe it as a North American manufacturer with distribution across Canada and the United States. No SEC filings are listed in the provided data, so regulatory reporting appears to be conducted primarily through Canadian securities channels and news releases.

Stock Performance

$0.1599
-8.47%
-0.0148
Last updated: November 16, 2026 at 16:00
-31.4%
Performance 1 year

Precision Peptide Company (PNGAF) closed at $0.1599 on November 16, 2026. Over the past 12 months, the price has lost 31.4%.

See what a $1,000 investment in PNGAF would be worth today

Average down calculator for PNGAF

PNGAF Metrics & Rankings

Price returns through November 16, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Precision Peptide Company has 10 recent news articles, with the latest published 5 days ago. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. View all PNGAF news →

SEC Filings

No SEC filings available for PNGAF.

Financial Highlights

We do not hold any annual figures for Precision Peptide Company yet, so there is nothing to show here.

Upcoming Events

JAN
2027
January 2027 Product

Receipt of patches

U.S.-manufactured 20,000 Thymosin Alpha-1 transdermal patches (2 mg each) from initial commercial production run expected Jan 2027; final quality review pending.
JAN
2027
January 2027 Operations

Production run receipt

Company expects receipt of 20,000 Thymosin Alpha-1 patches in Jan 2027; commercial release to follow after final quality review.
JAN
2027
January 2027 Operations

TA1 patch delivery

Delivery of 20,000 TA1 (Thymosin Alpha-1) patches expected in January 2027 per company; commercial order fulfillment timing.
JAN
2027
January 2027 Product

Thymosin Alpha-1 delivery

Delivery of 20,000-unit Thymosin Alpha-1 patch order expected in January 2027; supports U.S. commercial rollout and distribution.
YEAR
2027
2027 Product

2027 product launches

Company plans product launches and U.S. distribution expansion across 50 states during 2027, including new patch formulations.
JAN
2027
January 2027 Operations

TA1 units delivery

Delivery of 20,000 TA1 patch units from U.S. manufacturer expected January 2027; supports DTC and wholesale commercial rollouts.
JAN
15
January 15, 2027 Corporate

RSU vesting

300,000 RSUs vest at Precision Peptide (PNGAF) on 2027-01-15; equity vesting may dilute shares; no contact/webcast given.
APR
16
April 16, 2027 - April 16, 2029 Financial

Options exercisable period

800,000 consultant options exercisable over a 1–3 year period from grant (reported Apr 16, 2026); potential dilution risk.
JUL
31
July 31, 2036 Corporate

Option expiration

200,000 stock options expire on 2036-07-31; exercisable at $0.50 per share, 10-year term from grant date 2026-07-31.

Precision Peptide Company has 9 upcoming scheduled events. The next event, "Receipt of patches", is expected in January 2027. 1 of them is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the PNGAF stock price.

Short Interest History

Last 12 Months

Short interest in Precision Peptide Company (PNGAF) currently stands at 120.8 thousand shares, up 24050.0% from the previous reporting period, representing 0.1% of the float. Since December 2025, short interest has increased by 559.0%.

Days to Cover History

Last 12 Months

Days to cover for Precision Peptide Company (PNGAF) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 3.4 days.

PNGAF Company Profile & Sector Positioning

Precision Peptide Company (PNGAF) operates in the Packaged Foods industry within the broader Consumer Defensive sector and is listed on the OTC.

Investors comparing PNGAF often look at related companies in the same sector, including The Real Good Food A New (RGFC), Cellev8 Nutrition Inc (CELV), Glucose Health Inc (GLUC), Buron NutraScience Corp (BRCNF), and Starco Brands Inc (STCB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PNGAF's relative position within its industry.

Frequently Asked Questions

The current stock price of Precision Peptide Company (PNGAF) is $0.1599 as of November 16, 2026.

The market cap of Precision Peptide Company (PNGAF) is approximately $8.9M. Learn more about what market capitalization means .